Leishmaniasis.
Epidemiology, disease patterns, immunology, diagnosis, treatment and control measures of leishmaniasis are described. Various issues relating to leishmaniasis are highlighted: the relative lack of importance given to this disease compared with other infections, climate change and its possible impact on extension of endemicity of this infection, and new diagnostic tests which are improving diagnosis, especially in resource poor areas. Other important aspects discussed include the potential for newer oral therapy to change the way this disease is managed; Leishmania-HIV coinfection and groups at risk; and development of an effective vaccine.
Piscopo
Tonio V
TV
St Luke's Hospital, Guardamangia Hill, Guardamangia, MSD 09, Malta. tonio.piscopo@gov.mt
Mallia Azzopardi
Charles
C
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007111:Immunity, Cellular; D016773:Leishmaniasis, Cutaneous / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D007897:Leishmaniasis, Mucocutaneous / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D007898:Leishmaniasis, Visceral / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology
D000981:Antiprotozoal Agents